HHS Stock Analysis: Buy, Sell, or Hold?
$4.27
0.06 (1.43%)
▲
5d:
-1.61%
30d:
+88.94%
90d:
+65.5%
WAIT
LOW Confidence
Analysis Updated: Sep 4, 2026 12:00 AM ET
Earnings: Aug 20, 2026
0d
Get Alerted When HHS Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 MIXED SIGNALS: HHS shows conflicting indicators. Wait for confirmation before entering.
📊 MIXED SIGNALS: HHS shows conflicting indicators. Wait for confirmation before entering.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$4.05
Based on 7.0% avg growth
INTRINSIC VALUE TODAY
$2.51
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 2.7x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: HHS is currently trading at $4.27, which is considered extended relative to its 30-day fair value range of $2.43 to $4.26. From a valuation perspective, the stock is trading at a premium (Forward PE: 4.0) compared to its historical average (2.7). At these levels, the market is pricing in 14.5% annual earnings growth.
Technical Outlook: Technically, HHS is in a uptrend. Immediate support is located at $3.68, while resistance sits at $4.40.
Market Sentiment: HHS scores 0/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $17.50 (+309.8%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, HHS is in a uptrend. Immediate support is located at $3.68, while resistance sits at $4.40.
Market Sentiment: HHS scores 0/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $17.50 (+309.8%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$2.43 -
$4.26
Company Quality Score
31/100
(SELL)
Volume Confirmation
MODERATE
Confidence Score
27.1%
All Signals
- BEARISH: Price extended above range
- BEARISH: Weak technical setup (0/100)
- BULLISH: Trading 309.8% below Wall St target ($17.50)
- BULLISH: Expecting earnings turnaround to 14.5% growth with -1.7% revenue growth
- WARNING: Composite score 31/100 in the bottom quintile — this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$2.43 -
$4.26
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$3.68
Resistance Level
$4.40
Current Trend
Uptrend
Technical data as of
Sep 4, 2026
Fundamental Context
Forward P/E (Next Year Est.)
3.99
Wall Street Target
$17.50
(+309.8%)
Revenue Growth (YoY)
-1.7%
Earnings Growth (YoY)
-90.3%
Profit Margin
-3.7%
Valuation Premium vs History
+14.5% premium
PE vs Historical
4.0 vs 2.7
STRETCHED
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+14.5%
(market-implied from PE analysis)
1-Year Target
$4.89
(+15%)
2-Year Target
$5.60
(+31%)
3-Year Target
$6.41
(+50%)
3-Yr Target (if PE normalizes)
(PE: 4→3)
PE COMPRESSION
$4.34
(+2%)
Earnings growth offset by PE compression
Share & Embed Analysis
Last updated: September 05, 2026 7:41 PM ET
Data refreshes hourly during market hours. Next update: 8:41 PM
Data refreshes hourly during market hours. Next update: 8:41 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is HHS showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Conglomerates Stocks
Top-rated stocks in Conglomerates by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
HON
Honeywell International … |
BUY
26 analysts |
$264 | 59 HOLD |
|
MMM
3M Company |
BUY
19 analysts |
$186 | 55 HOLD |
|
BBU
Brookfield Business Part… |
STRONG BUY
6 analysts |
$41 | 52 HOLD |
|
VMI
Valmont Industries Inc |
STRONG BUY
5 analysts |
$625 | 56 HOLD |
|
PAM
Pampa Energia SA ADR |
BUY
8 analysts |
$121 | 40 SELL |